Dr. Jonathan M. Smith, MD

Dr. Smith practices at New Light Endo (Close) in Houston, Texas.

Dr. Smith's NPI, 1841546447, was assigned on August 1, 2012. Dr. Smith graduated from UT Southwestern Medical Center in 2010. Dr. Smith holds Texas license P6090.

Dr. Smith's primary practice is New Light Endo (Close), at 7777 Southwest Fwy, Houston, TX 77074 in Harris County. The practice phone is (713) 541-0000.

Dr. Smith's primary practice is New Light Endo (Close) in Houston, Texas. Dr. Smith is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UT Physicians. Dmand AI also links Dr. Smith to 4 more hospitals, 3 dialysis centers, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices, 11 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Smith is board certified in nephrology by the American Board of Internal Medicine. Dr. Smith is licensed in Texas.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Smith treats.

CMS data shows 866 Medicare services from Dr. Smith across 8 procedure codes in 2024, for 222 Medicare patients. Medicare paid $93,682 for them.

CMS counts 222 Medicare patients who saw Dr. Smith in 2024. The largest group is 75 to 84, with 74 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 4.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 69, with 45% women.

In 2024, Dr. Smith wrote 1,209 Medicare Part D claims for 165 patients. 80% of them were for generic drugs. CMS names the drug for 980 of them, across 28 drugs with 11 or more claims each, at $313,379 in total drug cost. In 2023, CMS named 892 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Smith for performance year 2024, reported individually. Dr. Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 57 general payments to Dr. Smith from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $401.

Dr. Smith graduated from UT Southwestern Medical Center in 2010.

Dr. Smith is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.